Duke-NUS collaborating on vaccine R&D programme
By Mustafa Shafawi | Posted: 27 January 2011 1436 hrs
SINGAPORE: The Duke-NUS Graduate Medical School is collaborating with US-based vaccine maker, Inviragen, on vaccine research.
The goal of the partnership is to better understand how emerging infectious diseases are transmitted and how transmission can be prevented.
Through this collaborative program, the two parties hope to advance the research and development of vaccines against infectious diseases such as dengue fever, hand, foot and mouth disease and chikungunya.
- CNA/fa
- wong chee tat :)
No comments:
Post a Comment